MAGNESIUM SULFATE IN DEXTROSE
Generic: MAGNESIUM SULFATE IN DEXTROSE
Baxter Healthcare CorporationManufacturer
INTRAVENOUSRoute
MAGNESIUM SULFATE HEPTAHYDRATEActive Substance
2020-08-11Original Approval
MAGNESIUM SULFATE IN DEXTROSE is FDA application ANDA211965, sponsored by BAXTER HLTHCARE CORP. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2012-04-05
Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, HoSuperpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium
Class I2026-03-18
Magnesium Sulfate in Water for Injection, 4g/100 mL (40mg/mL) IV bag, further packaged in cartons of 12 x 100 mL IV bagsProduct mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually
Class I2016-01-05
Magnesium Sulfate in Water for Injection, (0.325 mEq Mg++/mL) 40 mg/mL, 2 g Total, 50 mL Single-Dose Container bag, HospLabeling: Incorrect Barcode: Primary bag labeling may be mislabeled with the wrong barcode which sca
Class I2015-03-06
MAGNESIUM SULFATE IN 5% DEXTROSE INJECTION, USP, 10 mg/mL; 100 mL bag, Rx only, Hospira, Inc., Lake Forest, IL 60045, NLabeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect bar
Top Reported Reactions
1
DRUG INEFFECTIVE
1,238 reports
2
NAUSEA
894 reports
3
OFF LABEL USE
860 reports
4
PYREXIA
807 reports
5
MATERNAL EXPOSURE DURING PREGNANCY
780 reports
6
PAIN
711 reports
7
FOETAL EXPOSURE DURING PREGNANCY
707 reports
8
PREMATURE BABY
686 reports
9
DIARRHOEA
659 reports
10
DYSPNOEA
614 reports